NouvSight-001

N/A

Report date: 2024/03/22 09:29:45
First In Class

Base Information

Drug NameNouvSight-001
Drug Alias NameNouvSight001NouvSight-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRetinal Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Ruijian Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Ruijian Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinal Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A